Gemcitabine and cisplatin as a first line therapy in non-small cell lung cancer
Lung Cancer. 1998;21:S33 
Gemcitabine combination with cisplatin in advanced non-small cell lung cancer
Lung Cancer. 1999;25:S31-S32
2 The Hungarian experience with gemcitabine-cisplatin as first-line treatment of advanced non-small cell lung cancer: Focus on safety profile
Lung Cancer. 2003;41:S275
P0021 Gemcitabine–docetaxel versus cisplatin–gemcitabine as first-line therapy in patients with metastatic non-small-cell lung cancer
European Journal of Cancer. 2014;50:e15
P-480 A comparative study of combination chemotherapy with docetaxell cisplatin versus gemcitabine/cisplatin for locally advanced non-small cell lung cancer
Lung Cancer. 2005;49:S242-S243
An International, Multicenter, Randomized Phase III Study of First-Line Erlotinib Followed by Second-Line Cisplatin/Gemcitabine Versus First-Line Cisplatin/Gemcitabine Followed by Second-Line Erlotinib in Advanced Non–Small-Cell Lung Cancer: Treatment Rationale and Protocol Dynamics of the TORCH Trial
Clinical Lung Cancer. 2008;9(4):235-238
Gemcitabine combination therapy for non-small cell lung cancer
Lung Cancer. 1994;11:26-27
Combination of Gemcitabine and Cisplatin as First-Line Therapy in Advanced Non-Small-Cell Lung Cancer
Cancer Research and Treatment. 2004;36(3):173
Gemcitabine-Based Doublets for Advanced Non—Small-Cell Lung Cancer: Beyond Gemcitabine/Cisplatin
Clinical Lung Cancer. 2002;3:S10-S16
P-094 Gemcitabine, vinorelbine and cisplatin combination chemotherapy in advanced non-small cell lung cancer
Lung Cancer. 2005;49:S246-S247